Overall rank by patents
#48,900
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2021–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Multistars ranks #48,900 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R48900 · Foreign Corporation #48,900 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Mtorres Tissue S.R.L. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Multistars Biotechno… · this assignee
25 score
3D Lighting… · lowest
7 score
What this shows Multistars's Innovation Score is 24.9/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Multistars Biotechnology Company Limited is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (3 grants) versus a trough of 2 in 2022. By volume, Multistars sits between Mtorres Tissue S.R.L. and Muzlive Inc..
Multistars Biotechnology Company Limited shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mtorres Tissue S.R.L.
5 patents
MTU America Inc.
5 patents
Mulberry Black LLC
5 patents
Multiplicom N.V.
5 patents
Multy Home LP
5 patents
Muro Corporation
5 patents
Musthane
5 patents
Muzlive Inc.
5 patents
Multistars Biotechnology Company Limited
5 patents
What this shows Multistars holds 5 patents at rank #48,719, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,719 in granted patent volume.
Other assignees with the most granted patents in Multistars's primary technology class.
Multistars's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 16th percentile higher than 16% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 60.0% |
| 2022 | 2 | 40.0% |
Top 4 of 4 technology areas
Overall rank by patents
#48,900
of 49,997 tracked assignees
24.9 out of 100
What to do with this data
Multistars Biotechnology Company Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.